{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-075720","form_type":"8-K","ticker":"GPCR","cik":"0001888886","company_name":"Structure Therapeutics Inc.","filed_at":"2026-06-18T20:05:25+00:00","discovered_at":"2026-06-18T20:07:00.329497+00:00","generated_at":"2026-06-18T20:12:05.554866+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Structure Therapeutics shareholders elect directors, ratify auditor, approve say-on-pay at 2026 AGM","bullets":["Elected Ted W. Love, Raymond Stevens, Daniel G. Welch as Class III directors with >161M votes for each.","Ratified Ernst & Young as independent auditor for FY2026: 164.8M for, 20.8K against.","Advisory vote on executive compensation approved: 158.5M for, 6.2M against, 212.7K abstentions.","213.2M ordinary shares outstanding as of record date April 20, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-075720","json":"https://secwatch.observer/filing/0001104659-26-075720.json","markdown":"https://secwatch.observer/filing/0001104659-26-075720.md","text":"https://secwatch.observer/filing/0001104659-26-075720.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1888886/000110465926075720/0001104659-26-075720-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1888886/000110465926075720/tm2618249d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T20:12:05.554866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8d5e77547e0ed69bacef5bcd3a7fcf92440f2780","claim":"Structure Therapeutics Inc. shareholders approved Election of Directors at the 2026-06-17 meeting.","evidence_excerpt":"Proposal 1: Election of Directors Ted W. Love M.D., Raymond Stevens, Ph.D. and Daniel G. Welch were elected as a Class III directors, to hold office until the 2029 Annual General Meeting of Shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1888886/000110465926075720/0001104659-26-075720-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"},{"claim_id":"8dd2597fb740f99051324d8f11dcb520aa926085","claim":"Structure Therapeutics Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-17 meeting.","evidence_excerpt":"Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The Company’s shareholders ratified the appointment by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1888886/000110465926075720/0001104659-26-075720-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"},{"claim_id":"fdedc33de50b408feaab591e1ebec0f69f6a4737","claim":"Structure Therapeutics Inc. shareholders approved Advisory vote on the compensation of the Company’s named executive officers at the 2026-06-17 meeting.","evidence_excerpt":"Proposal 3: Advisory vote on the compensation of the Company’s named executive officers On an advisory basis, the shareholders approved the compensation of the Company’s named executive officers, as disclosed in the Company’s proxy statement for the Annual General Meeting.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1888886/000110465926075720/0001104659-26-075720-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}